$1.08
-0.04-3.57%
At close: -
$1.06
-0.02-1.74%
After Hours: 4:46 PM EDT
Comments
Loading...
Werewolf Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:HOWL | Benzinga
Werewolf Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 2
EPS Estimate
$-0.360
Quarterly Revenue Estimate
$375.00K
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$1.89M
Analyze the earnings history of Werewolf Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| HOWL | Werewolf Therapeutics | -$0.39 | -$0.36 | — | — | $742.00K | $375.00K | — | — | 05/02/2025 | Get Alert |
| HOWL | Werewolf Therapeutics | -$0.33 | -$0.28 | -$0.46 | -64.29% | $1.50M | $301.59K | $0.00 | -100.00% | 03/11/2025 | Get Alert |
| HOWL | Werewolf Therapeutics | -$0.23 | -$0.41 | -$0.38 | 7.32% | $5.90M | $710.00K | $0.00 | -100.00% | 11/07/2024 | Get Alert |
| HOWL | Werewolf Therapeutics | -$0.14 | -$0.38 | -$0.43 | -13.16% | $8.08M | $840.00K | $1.14M | 36.07% | 08/08/2024 | Get Alert |
| HOWL | Werewolf Therapeutics | -$0.34 | -$0.35 | -$0.39 | -11.43% | $4.46M | $1.82M | $742.00K | -59.23% | 05/03/2024 | Get Alert |
| HOWL | Werewolf Therapeutics | -$0.39 | -$0.43 | -$0.33 | 23.26% | $7.28M | $1.94M | $1.50M | -22.63% | 03/07/2024 | Get Alert |
| HOWL | Werewolf Therapeutics | -$0.40 | -$0.39 | -$0.23 | 41.03% | $4.97M | $1.59M | $5.90M | 270.88% | 11/14/2023 | Get Alert |
| HOWL | Werewolf Therapeutics | -$0.53 | -$0.42 | -$0.14 | 66.67% | $4.15M | $2.46M | $8.08M | 228.50% | 08/10/2023 | Get Alert |
| HOWL | Werewolf Therapeutics | -$0.56 | -$0.50 | -$0.34 | 32.00% | $0.00 | $5.00M | $4.46M | -10.72% | 05/11/2023 | Get Alert |
| HOWL | Werewolf Therapeutics | -$0.66 | -$0.55 | -$0.39 | 29.09% | $0.00 | $2.07M | $7.28M | 251.84% | 03/23/2023 | Get Alert |
| HOWL | Werewolf Therapeutics | -$0.51 | -$0.60 | -$0.40 | 33.33% | $0.00 | — | $4.97M | — | 11/10/2022 | Get Alert |
| HOWL | Werewolf Therapeutics | -$3.82 | -$0.43 | -$0.53 | -23.26% | $0.00 | — | $4.15M | — | 08/11/2022 | Get Alert |
| HOWL | Werewolf Therapeutics | -$83.36 | -$0.61 | -$0.56 | 8.20% | $0.00 | — | $0.00 | — | 05/10/2022 | Get Alert |
| HOWL | Werewolf Therapeutics | -$17.85 | -$0.53 | -$0.66 | -24.53% | $0.00 | — | $0.00 | — | 03/24/2022 | Get Alert |
| HOWL | Werewolf Therapeutics | -$6.61 | -$0.44 | -$0.51 | -15.91% | — | — | $0.00 | — | 11/10/2021 | Get Alert |
| HOWL | Werewolf Therapeutics | $0.22 | -$0.37 | -$3.82 | -932.43% | — | — | $0.00 | — | 08/12/2021 | Get Alert |
| HOWL | Werewolf Therapeutics | — | — | -$83.36 | — | — | — | $0.00 | — | 06/10/2021 | Get Alert |
Werewolf Therapeutics (HOWL) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-11 | $-0.46 | $-0.28 | -64.3 % |
| Q3 | 2024-11-07 | $-0.38 | $-0.41 | 7.32 % |
| Q2 | 2024-08-08 | $-0.43 | $-0.38 | -13.2 % |
| Q1 | 2024-05-03 | $-0.39 | $-0.35 | -11.4 % |
Werewolf Therapeutics (HOWL) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-11 | $0 | $301.59K | -100.0 % |
| Q3 | 2024-11-07 | $0 | $710.00K | -100.0 % |
| Q2 | 2024-08-08 | $1.14M | $840.00K | 36.1 % |
| Q1 | 2024-05-03 | $742.00K | $1.82M | -59.2 % |
FAQ
When is Werewolf Therapeutics (NASDAQ:HOWL) reporting earnings?
Werewolf Therapeutics (HOWL) is scheduled to report earnings on May 2, 2025. The last reported earnings were for reported on March 11, 2025 for Q4.
What were the latest earnings per share (EPS) for Werewolf Therapeutics (NASDAQ:HOWL)?
The Actual EPS was $-0.46, which missed the estimate of $-0.28.
What were Werewolf Therapeutics’s (NASDAQ:HOWL) revenues?
The Actual Revenue was $0K, which missed the estimate of $301.6K.
Browse earnings estimates, EPS, and revenue on all stocks.